Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-03-14

FDA Approved: SUMATRIPTAN SUCCINATE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Sumatriptan succinate from Sun Pharmaceutical Industries, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sumatriptan succinate (Sumatriptan succinate)

Snippet

SUPPL AP for SUMATRIPTAN SUCCINATE (SUMATRIPTAN SUCCINATE)